April 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the addition of two senior officers that ...

The latest price target for Microbot Medical (NASDAQ:MBOT) was reported by HC Wainwright & Co. on April 10, 2025. The analyst firm set a price target for $9.00 expecting MBOT to rise to within 12 ...

Shares of MBOT opened at $2.23 on Monday. The company’s fifty day moving average price is $1.67 and its 200-day moving average price is $1.38. Microbot Medical has a 1-year low of $0.82 and a 1 ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...